Rosen Steven H's Form 4 filing
Invacare Holdings CorpIVC · filed Nov 16, 2022
- Accession no.
- 0000899243-22-036080
- Filed
- Nov 16, 2022, 9:53 PM ET
- Trade date
- Nov 14-16, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $78.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rosen Steven HCIK 0001535144 | Director, 10% Owner, Other: Member of a 10% owner group |
| Azurite Management LLCCIK 0001933086 | 10% Owner, Other: Member of a 10% owner group |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2022 | Common Shares, no par value | SSaleDisposed | −60,480 | $0.502F1,F5 | −$30,360.96 | 3,886,078 | Indirect | |
| Nov 15, 2022 | Common Shares, no par value | SSaleDisposed | −78,025 | $0.496F2,F5 | −$38,700.4 | 3,808,053 | Indirect | |
| Nov 16, 2022 | Common Shares, no par value | SSaleDisposed | −20,000 | $0.486F3,F5 | −$9,720 | 3,788,053 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in column 4 is a weighted average price. These common shares, no par value (the "Common Shares"), were sold in multiple transactions at prices ranging from $0.510 to $0.517, inclusive. The Reporting Persons undertake to provide to Invacare Corporation (the "Issuer"), any securityholder of the Issuer or the staff of the Securities and Exchange Commission ("SEC Staff"), upon request, full information regarding the number of shares sold at each price within the range specified herein.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.500 to $0.505, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in column 4 is a weighted average price. These Common Shares were sold in multiple transactions at prices ranging from $0.490 to $0.493, inclusive. The Reporting Persons undertake to provide to the Issuer, any securityholder of the Issuer or the SEC Staff, upon request, full information regarding the number of shares sold at each price within the range specified herein.
Referenced by the price of 1 transaction in Table I.
- F5
This Form 4 is being filed as a result of sales of Common Shares by Azurite. The sales were effected at prices below the prices of the purchases reported in the Form 4s filed by the Reporting Persons on June 7, 2022 (as amended on June 8, 2022) and June 27, 2022, such that there is no profit for purposes of Section 16(b) and the rules promulgated thereunder.
Referenced by the price of 3 transactions in Table I.
Remarks
The Reporting Persons (Mr. Rosen and Azurite), along with Crawford United Corporation ("Crawford United"), Edward F. Crawford and Matthew V. Crawford, comprise a group within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended. Crawford United and Messrs. Crawford separately own Common Shares of the Issuer. The Reporting Persons disclaim beneficial ownership over the Common Shares separately owned by Crawford United and Messrs. Crawford and any other Common Shares owned by the group, except to the extent of their respective pecuniary interest therein.